Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

695 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sensitive detection of FGFR3 mutations in bladder cancer and urine sediments by peptide nucleic acid-mediated real-time PCR clamping.
Miyake M, Sugano K, Kawashima K, Ichikawa H, Hirabayashi K, Kodama T, Fujimoto H, Kakizoe T, Kanai Y, Fujimoto K, Hirao Y. Miyake M, et al. Among authors: hirabayashi k. Biochem Biophys Res Commun. 2007 Nov 3;362(4):865-71. doi: 10.1016/j.bbrc.2007.08.092. Epub 2007 Aug 27. Biochem Biophys Res Commun. 2007. PMID: 17803960
Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer.
Miyake M, Sugano K, Sugino H, Imai K, Matsumoto E, Maeda K, Fukuzono S, Ichikawa H, Kawashima K, Hirabayashi K, Kodama T, Fujimoto H, Kakizoe T, Kanai Y, Fujimoto K, Hirao Y. Miyake M, et al. Among authors: hirabayashi k. Cancer Sci. 2010 Jan;101(1):250-8. doi: 10.1111/j.1349-7006.2009.01334.x. Epub 2009 Sep 1. Cancer Sci. 2010. PMID: 19843069 Free article.
Long-term results of dose-intensive chemotherapy with G-CSF support (TCC-NHL-91) for advanced intermediate-grade non-Hodgkin's lymphoma: a review of 59 consecutive cases treated at a single institute.
Akutsu M, Tsunoda S, Izumi T, Tanaka M, Katano S, Inoue K, Igarashi S, Hirabayashi K, Furukawa Y, Ohmine K, Sato K, Kobayashi H, Ozawa K, Kirito K, Nagashima T, Teramukai S, Fukushima M, Kano Y. Akutsu M, et al. Among authors: hirabayashi k. Oncol Res. 2008;17(3):137-49. doi: 10.3727/096504008785055549. Oncol Res. 2008. PMID: 18669165
Rapid progression of a granulocyte colony-stimulating factor-producing liver tumor metastasized from esophagogastric junction cancer: A case report and literature review.
Hoshimoto S, Hoshi N, Ozawa I, Tomikawa M, Shirakawa H, Fujita T, Wakamatsu S, Hoshi S, Hirabayashi K, Hishinuma S, Ogata Y. Hoshimoto S, et al. Among authors: hirabayashi k. Oncol Lett. 2018 May;15(5):6475-6480. doi: 10.3892/ol.2018.8144. Epub 2018 Mar 1. Oncol Lett. 2018. PMID: 29725401 Free PMC article.
695 results